<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01152502</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0076</org_study_id>
    <nct_id>NCT01152502</nct_id>
  </id_info>
  <brief_title>Paracetamol Metabolism in Post Operative Conditions</brief_title>
  <official_title>Paracetamol Metabolism in Post Operative Conditions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      Follow-up of urinary concentration from paracetamol metabolites by patients with aortic
      surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      D-15 to D0: selection

        -  patient information and non-opposition obtained

        -  inclusion and non inclusion criteria check

        -  clinical exam

      D-1 to D0 : 24 hours diuresis

      D0 : operation day

      Before anesthesia :

        -  urine collection (paracetamol metabolites dosage)

        -  blood sampling (glutathion and liver function test)

      Surgery:

        -  1st paracetamol intake before closing

        -  Then administration every 6 hours

      D1 to D4 :

        -  24 hours urine collection (metabolites dosage)

        -  blood sampling et D1 and D4(glutathion and liver function test)

      D5 : final clinical exam
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">June 2010</completion_date>
  <primary_completion_date type="Actual">September 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Follow-up of urinary concentration from paracetamol metabolites by patients with aortic surgery during 4 days therapeutic intake (perfalgan ® 4 x 1g IV/day)</measure>
    <time_frame>during 4 days therapeutic intake</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>- Follow-up of glutathion concentration during 4 post operative days</measure>
    <time_frame>during 4 post operative days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Monitoring of liver function</measure>
  </secondary_outcome>
  <enrollment type="Actual">30</enrollment>
  <condition>Aortic Surgery and Treatment Post Operative With Paracetamol During 4 Days</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Defined population
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aortic surgery

          -  treatment with intraveinous paracetamol (4 grammes daily during 4 days)

          -  patient agrees to participate

        Exclusion Criteria:

          -  - patient disagrees

          -  paracetamol contra-indication

          -  paracetamol intake 5 days before surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric SCHNEIDER</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 28, 2010</study_first_submitted>
  <study_first_submitted_qc>June 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 29, 2010</study_first_posted>
  <last_update_submitted>June 28, 2010</last_update_submitted>
  <last_update_submitted_qc>June 28, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Patrick LACARIN</name_title>
    <organization>CHU Clermont-Ferrand</organization>
  </responsible_party>
  <keyword>Post operative conditions, paracetamol metabolites</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

